Skip to main content

Thyrotoxicosis Linked to Risk for Incident Cognitive Disorder

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 28, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 28, 2023 -- For older adults, exposure to a low thyrotropin (TSH) level from either endogenous or exogenous thyrotoxicosis is associated with an increased risk for incident cognitive disorder, according to a study recently published in JAMA Internal Medicine.

Roy Adams, Ph.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a cohort study to examine whether thyrotoxicosis is associated with an increased risk for cognitive disorders. Patients aged 65 years and older with at least two visits to their primary care physicians 30 days apart were eligible; the analysis included 65,931 patients. The exposure variable was low TSH level, characterized based on the clinical context as due to endogenous thyrotoxicosis, exogenous thyrotoxicosis, or unknown cause.

The researchers found that the incidence of cognitive disorder was 11.0 and 6.4 percent by age 75 years for patients exposed and not exposed, respectively, to thyrotoxicosis. Across age groups, all-cause thyrotoxicosis was associated with the risk for cognitive disorder diagnosis after adjustment (adjusted hazard ratio, 1.39). Exogenous thyrotoxicosis remained a significant risk factor when stratified by cause and severity (adjusted hazard ratio, 1.34), with point estimates indicating a dose response.

"An increased risk of cognitive disorders is among the potential negative consequences of thyroid hormone excess, a common consequence of thyroid hormone treatment," the authors write.

One author disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181

MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...

Lower Cognitive Function in Adolescence Linked to Stroke Risk

FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.